Samsara Inc vs Mesoblast Limited — how do they compare? Samsara Inc trades at $39.95 (market cap $23.49B), while Mesoblast Limited trades at $17.03 (market cap $2.21B). The key difference: Samsara Inc is far larger — about 10.6× Mesoblast Limited's market cap, and Samsara Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| IOT | MESO | |
|---|---|---|
Market Cap | $23.49B | $2.21B |
Sector | Technology | Technology |
52-Week High | $45.22 | $20.96 |
52-Week Low | $24.25 | $12.88 |
Enterprise Value | $22.76B | $2.21B |
Trailing returns across standard periods
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →